The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis
Open Access
- 1 January 2026
- journal article
- review article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2026 (1)
Abstract
Introduction: Diet significantly influences the progression of inflammatory bowel disease (IBD). The Mediterranean diet (MD), characterized by high consumption of fruits, vegetables, healthy fats, lean proteins, and limited intake of processed foods, is recommended as adjunctive therapy. This meta‐analysis is aimed at evaluating existing data on dietary management in ulcerative colitis (UC) and assessing the effectiveness of MD in achieving symptomatic remission or improvement in IBD patients compared with other dietary interventions. Methods: Following Cochrane and PRISMA guidelines, we compared MD with alternative dietary interventions in IBD patients. Randomized controlled trials (RCTs) were identified through comprehensive database searches up to November 2024. Data were analyzed using RevMan Web, employing a random‐effects model. Results: Four RCTs involving a total of 339 IBD patients were included in this analysis. Among these, 167 patients (UC and CD) received the MD, whereas 172 followed non‐Mediterranean diets (NMD). The MD was associated with a statistically significant improvement in clinical remission compared with NMD (RR 1.18, p = 0.02). In subgroup analyses, clinical remission was not statistically different in UC (RR 1.15, 95% CI: 0.94–1.41, p = 0.78) or CD (RR 1.22, 95% CI: 1.00–1.47, p = 0.05). When compared specifically with a regular diet, MD significantly reduced both CRP levels (MD −2.66, p < 0.00001) and fecal calprotectin (MD −229.46, p = 0.008). Specifically, within the UC population, MD significantly decreased CRP and fecal calprotectin levels. Discussion: Our findings indicate that the MD significantly benefits IBD management, especially UC, as demonstrated by notable reductions in inflammatory markers. Benefits in CD remain unclear despite prior evidence. Future research should clarify benefits across patient subgroups and address adherence challenges.Keywords
Funding Information
- Pennsylvania State University
This publication has 35 references indexed in Scilit:
- Mo1730 SPECIFIC CARBOHYDRATE DIET VERSUS MEDITERRANEAN DIET IN ADULT PATIENTS WITH MILD TO MODERATE ULCERATIVE COLITIS: A RANDOMIZED CONTROLLED-FEEDING TRIALGastroenterology, 2024
- Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2022
- Effect of dietary interventions on inflammatory biomarkers of inflammatory bowel diseases: A systematic review of clinical trialsNutrition, 2021
- Inflammatory Bowel Disease Presentation and DiagnosisSurgical Clinics of North America, 2019
- Adherence to Mediterranean diet in Crohn’s diseaseEuropean Journal of Nutrition, 2019
- Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialThe Lancet, 2017
- Methods for including information from multi‐arm trials in pairwise meta‐analysisResearch Synthesis Methods, 2017
- Consumption of a healthy dietary pattern results in significant reductions in C-reactive protein levels in adults: a meta-analysisNutrition Research, 2016
- Role of nutrition and microbiota in susceptibility to inflammatory bowel diseasesMolecular Nutrition & Food Research, 2012
- Detecting and adjusting for small‐study effects in meta‐analysisBiometrical Journal, 2011